The effect of inofolic powder on fertility in women with polycystic ovary syndrom

Phase 2

• Conditions: Polycystic ovary syndrome.; ICD-10 Chapter XV: Pregnancy, childbirth and the puerperium; ICD-10 Cha

• Registration Number: IRCT20220308054221N1
• Lead Sponsor: Ilam University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Women who have a proven history of polycystic ovary syndrome, tests, and ultrasound
Clinical signs such as oligomenorrhea, irregular menstrual cycle and androgen-induced symptoms

Exclusion Criteria

History of ovarian surgery in the last three months
use of antiepileptic drugs and glucocorticoids
congenital adrenal hyperplasia
hypothyroidism, hyperthyroidism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of infertile women who have had a positive pregnancy. Timepoint: Positive fertility in the first month or the second month or the third month after starting to use inofolic powder. Method of measurement: Positive B-hcg test and ultrasound.

Secondary Outcome Measures

Name	Time	Method
Increase the number and size of follicles. Timepoint: The first month, the second month and the third month after the start of inofolic powder. Method of measurement: sonography.